SPAC3F10.12c Antibody

What applications is the SPAC3F10.12c antibody validated for?

The SPAC3F10.12c antibody has been specifically validated for ELISA (Enzyme-Linked Immunosorbent Assay) and WB (Western Blot) applications in yeast species . These techniques allow researchers to detect and quantify the SPAC3F10.12c protein in experimental samples. The antibody's specificity for yeast makes it particularly valuable for studies focusing on Schizosaccharomyces pombe cellular biology and protein expression patterns.

What is the source and isotype of the SPAC3F10.12c antibody?

The SPAC3F10.12c antibody is a rabbit polyclonal antibody with IgG isotype . It is generated by immunizing rabbits with recombinant Schizosaccharomyces pombe (strain 972/ATCC 24843) SPAC3F10.12c protein. The antibody is affinity-purified, which enhances its specificity for the target protein. Polyclonal antibodies offer advantages in recognizing multiple epitopes on the target protein, potentially increasing detection sensitivity.

What are the recommended storage conditions for SPAC3F10.12c antibody?

The SPAC3F10.12c antibody should be stored at -20°C or -80°C to maintain its functionality and specificity . Proper storage is critical for preserving antibody activity and preventing degradation. Researchers should avoid repeated freeze-thaw cycles, which can diminish antibody performance. For working solutions, aliquoting the antibody before storage is recommended to minimize freeze-thaw events.

How should SPAC3F10.12c antibody be validated for specificity in fission yeast studies?

To validate SPAC3F10.12c antibody specificity in fission yeast studies, researchers should implement a multi-step approach:

• Knockout Controls: Compare antibody reactivity between wild-type and SPAC3F10.12c knockout strains in Western blot analyses.

• Overexpression Controls: Test antibody with samples overexpressing the tagged target protein.

• Peptide Competition Assay: Pre-incubate the antibody with purified SPAC3F10.12c protein before application to determine if binding is competitively inhibited.

• Cross-Reactivity Testing: Examine potential cross-reactivity with related proteins in S. pombe.

• Immunoprecipitation Validation: Confirm that the immunoprecipitated protein corresponds to SPAC3F10.12c by mass spectrometry.

The antibody components provided include 200 μg antigens (positive control), 1 ml pre-immune serum (negative control), and rabbit polyclonal antibodies purified by Antigen Affinity , which facilitate comprehensive validation protocols.

What are the optimal dilution ratios for SPAC3F10.12c antibody in different applications?

Note: Exact dilutions should be determined experimentally for each specific protocol and sample type. Initial titration experiments are recommended to establish optimal antibody concentration for signal-to-noise ratio.

The antibody should be tested alongside the provided positive control (antigens) and negative control (pre-immune serum) to establish appropriate working dilutions for specific experimental conditions .

How can researchers troubleshoot non-specific binding when using SPAC3F10.12c antibody?

When troubleshooting non-specific binding with SPAC3F10.12c antibody, consider the following methodological approaches:

• Blocking Optimization: Test different blocking agents (BSA, non-fat milk, commercial blockers) at various concentrations (3-5%) to identify optimal conditions.

• Antibody Dilution: Increase the antibody dilution incrementally to reduce background while maintaining specific signal.

• Washing Protocol Enhancement: Increase washing duration and frequency using buffers with varied detergent concentrations (0.05-0.1% Tween-20).

• Sample Preparation: Ensure complete lysis of yeast cells using optimized protocols for S. pombe, which typically require mechanical disruption combined with enzymatic treatment due to their robust cell walls.

• Pre-absorption Strategy: Pre-absorb the antibody with acetone powder from control yeast lacking the target protein to remove antibodies that recognize common yeast epitopes.

• Secondary Antibody Alternatives: Test different anti-rabbit secondary antibodies from various manufacturers if non-specific binding persists.

The provided pre-immune serum serves as an essential negative control to identify and distinguish non-specific binding patterns .

How can SPAC3F10.12c antibody be adapted for chromatin immunoprecipitation (ChIP) experiments?

While the SPAC3F10.12c antibody is primarily validated for ELISA and Western blot applications , adapting it for ChIP experiments requires protocol modifications:

• Cross-linking Optimization: For yeast cells, use 1% formaldehyde for 15-20 minutes at room temperature, followed by quenching with 125 mM glycine.

• Cell Wall Disruption: Implement specialized enzymatic digestion with zymolyase (100T at 1 mg/ml) for 30 minutes at 30°C to effectively disrupt the yeast cell wall before sonication.

• Chromatin Fragmentation: Use sonication parameters specific for yeast (typically 15-20 cycles of 30 seconds on/30 seconds off) to achieve optimal DNA fragment sizes of 200-500 bp.

• Antibody Binding: Increase antibody concentration (5-10 μg per reaction) and incubation time (overnight at 4°C) to compensate for the more complex chromatin environment.

• Protein-DNA Complex Isolation: Use magnetic beads conjugated with Protein A rather than Protein G, as the antibody is rabbit-derived IgG which has higher affinity for Protein A.

• Stringent Washing: Implement more stringent washing conditions (increasing salt concentration in wash buffers from 150 mM to 500 mM NaCl) to reduce background.

• Controls: Include parallel ChIP experiments with pre-immune serum and IgG to establish background levels.

Prior to large-scale experiments, preliminary studies should verify the antibody's suitability for ChIP applications with the target protein.

What considerations are important when using SPAC3F10.12c antibody in co-immunoprecipitation (Co-IP) studies?

For successful Co-IP studies using SPAC3F10.12c antibody, researchers should consider:

• Lysis Buffer Composition: Use gentle lysis buffers containing:

  • 50 mM HEPES pH 7.5

  • 150 mM NaCl

  • 1 mM EDTA

  • 1% Triton X-100

  • 0.1% Sodium deoxycholate

  • Protease inhibitor cocktail

• Cross-linking Considerations: For transient interactions, implement reversible cross-linkers like DSP (dithiobis(succinimidyl propionate)) at 1-2 mM for 30 minutes at room temperature.

• Antibody Coupling Strategy: Pre-couple the antibody to Protein A/G beads (4-5 μg antibody per 50 μl bead slurry) before adding lysate to minimize co-elution of antibody heavy chains that may interfere with detection.

• Pre-clearing Protocol: Pre-clear lysates with Protein A/G beads for 1 hour at 4°C to reduce non-specific binding before adding antibody-coupled beads.

• Sequential Co-IP Approach: For complex interaction networks, consider sequential Co-IP where the first immunoprecipitation product becomes the input for a second round using antibodies against suspected interaction partners.

• Elution Conditions: Use competitive elution with excess SPAC3F10.12c peptide (100-200 μg/ml) rather than harsh elution buffers to preserve weak interactions.

• Mass Spectrometry Compatibility: For downstream proteomics analysis, avoid detergents like SDS and NP-40, instead using MS-compatible alternatives such as RapiGest or ProteaseMAX.

The affinity-purified nature of the SPAC3F10.12c antibody makes it potentially suitable for Co-IP applications, though optimization will be required.

How might researchers use SPAC3F10.12c antibody in studying TSC pathway signaling in fission yeast models?

The fission yeast model has been valuable for dissecting TSC pathway components . To utilize SPAC3F10.12c antibody in these studies:

• Pathway Component Localization:

  • Use the antibody for immunofluorescence to track SPAC3F10.12c protein localization changes under nitrogen starvation conditions, which trigger TSC pathway responses in fission yeast.

  • Compare localization patterns between wild-type and tsc1Δ or tsc2Δ mutants to establish functional relationships.

• Protein Interaction Dynamics:

  • Implement Co-IP experiments to identify interactions between SPAC3F10.12c and known TSC pathway components like Rhb1 (RHEB homolog) or Tor2 (mTOR homolog).

  • Compare interaction profiles under nutrient-rich versus starvation conditions.

• Expression Level Monitoring:

  • Quantify SPAC3F10.12c protein levels in response to pathway modulators using quantitative Western blotting.

  • Compare protein stability and turnover rates between wild-type and pathway mutants.

• Genetic Interaction Analysis:

  • Create SPAC3F10.12c knockout strains combined with mutations in TSC pathway genes.

  • Use the antibody to confirm protein absence in knockout strains and examine compensatory expression changes in other pathway components.

• Signaling Cascade Mapping:

  • Determine SPAC3F10.12c's position in the signaling cascade by examining its phosphorylation state in response to pathway activation or inhibition.

  • Use phospho-specific antibodies in combination with the SPAC3F10.12c antibody to correlate phosphorylation with protein function.

Since fission yeast TSC pathway regulates responses to nitrogen starvation , experiments should include both nitrogen-rich and nitrogen-starved conditions to identify condition-dependent changes in SPAC3F10.12c behavior.

What approaches can be used to evaluate post-translational modifications of SPAC3F10.12c using the antibody?

To evaluate post-translational modifications (PTMs) of SPAC3F10.12c:

• 2D Gel Electrophoresis with Western Blotting:

  • Separate proteins by isoelectric point and molecular weight to distinguish differently modified versions.

  • Use the SPAC3F10.12c antibody for Western blotting to detect all forms of the protein.

  • Changes in spot patterns indicate PTMs that alter charge or mass.

• PTM-Specific Detection Methods:

  • For phosphorylation: Treat samples with lambda phosphatase before Western blotting to confirm phosphorylation by mobility shift.

  • For ubiquitination: Perform immunoprecipitation under denaturing conditions followed by detection with anti-ubiquitin antibodies.

  • For SUMOylation: Use SUMO-specific antibodies on immunoprecipitated SPAC3F10.12c.

• Mass Spectrometry Approach:

  • Immunoprecipitate SPAC3F10.12c using the antibody.

  • Digest purified protein with trypsin and analyze by LC-MS/MS.

  • Search for mass shifts characteristic of specific PTMs.

• PTM Site Mutational Analysis:

  • Generate S. pombe strains expressing SPAC3F10.12c with mutations at predicted PTM sites.

  • Compare antibody reactivity with wild-type and mutant proteins to assess contribution of specific sites.

• Temporal Dynamics Study:

  • Apply stimuli known to trigger signaling cascades (nutrient limitation, stress conditions).

  • Collect samples at defined time points and immunoprecipitate SPAC3F10.12c.

  • Analyze PTM patterns to establish modification kinetics.

This polyclonal antibody's ability to recognize multiple epitopes makes it useful for detecting the protein regardless of modifications, though it may not distinguish between modified forms without additional techniques.

How does antibody-based detection of SPAC3F10.12c compare with other protein detection methods in fission yeast?

The affinity-purified SPAC3F10.12c antibody provides particular advantages for examining the endogenous protein without genetic modification, while enabling detection of potential post-translational modifications that may be missed by tagged protein methods.

What are the implications of using a polyclonal versus monoclonal antibody for SPAC3F10.12c research?

How can SPAC3F10.12c antibody research findings be integrated with high-throughput omics studies in fission yeast?

Integrating SPAC3F10.12c antibody research with omics studies requires strategic approaches:

• Proteome-Antibody Integration:

  • Use the antibody for targeted validation of SPAC3F10.12c identification in shotgun proteomics datasets.

  • Employ immunoprecipitation followed by mass spectrometry (IP-MS) to identify SPAC3F10.12c interaction partners and compare with predicted interactome data.

  • Validate protein abundance changes detected in proteomics studies with quantitative Western blotting using the SPAC3F10.12c antibody.

• Transcriptome Correlation:

  • Compare SPAC3F10.12c protein levels (detected by the antibody) with mRNA expression profiles to identify post-transcriptional regulation mechanisms.

  • Use the antibody to isolate SPAC3F10.12c-containing ribonucleoprotein complexes for RNA immunoprecipitation sequencing (RIP-seq) if RNA-binding functionality is suspected.

• Epigenome Studies:

  • If SPAC3F10.12c has nuclear functions, employ ChIP-seq using the antibody to map genome-wide binding sites.

  • Correlate binding patterns with histone modification maps and transcription profiles.

• Metabolome Integration:

  • Use the antibody to modulate SPAC3F10.12c function (through direct inhibition or depletion) and measure resulting metabolic changes.

  • Compare metabolic profiles between wild-type and SPAC3F10.12c mutant strains.

• Network Analysis Framework:

  • Position SPAC3F10.12c within yeast functional networks by combining antibody-based interaction studies with computational predictions.

  • Use Cytoscape or similar network visualization tools to integrate multiple omics datasets with SPAC3F10.12c-centered experimental data.

• Multi-condition Experimental Design:

  • Apply the antibody across multiple environmental conditions (nutrient limitation, stress, cell cycle phases) that trigger different omics profiles.

  • Develop correlation matrices between SPAC3F10.12c localization/modification status and broader cellular responses.

The availability of both the antibody and control materials enables researchers to generate high-confidence protein-level data that can contextually enrich broader omics datasets.

What emerging technologies might enhance the utility of SPAC3F10.12c antibody in yeast research?

Several emerging technologies could significantly enhance SPAC3F10.12c antibody applications:

• Proximity Labeling Methods:

  • Adapting BioID or APEX2 proximity labeling with SPAC3F10.12c antibody for immunoprecipitation could map spatial interactomes.

  • This would involve creating fusion proteins with biotin ligases, followed by streptavidin pulldown and verification with the SPAC3F10.12c antibody.

• Super-Resolution Microscopy:

  • Techniques like STORM or PALM could enhance visualization of SPAC3F10.12c localization beyond diffraction limits when used with fluorophore-conjugated antibodies.

  • This would reveal previously undetectable subcellular distribution patterns.

• Single-Cell Proteomics:

  • Combining SPAC3F10.12c antibody with microfluidic platforms could enable protein quantification at single-cell resolution.

  • This would address heterogeneity questions in yeast populations that bulk methods cannot resolve.

• Spatial Transcriptomics Integration:

  • Correlating SPAC3F10.12c protein localization with spatial mRNA distribution using multiplexed FISH techniques.

  • This would elucidate relationships between mRNA localization and protein distribution.

• Antibody-based CRISPR Techniques:

  • Using the antibody to deliver CRISPR-Cas9 components to SPAC3F10.12c proximity for precise genome editing.

  • This could enable functional studies through targeted modifications of genes physically associated with SPAC3F10.12c.

• Microfluidic Antibody Arrays:

  • Developing microfluidic platforms with immobilized SPAC3F10.12c antibody for real-time monitoring of protein dynamics in yeast extracts.

  • This would allow temporal profiling of protein expression under changing conditions.

• Nanobody Development:

  • Engineering smaller antibody fragments (nanobodies) based on SPAC3F10.12c antibody epitopes.

  • This would enhance penetration in intact yeast cells and reduce background in imaging applications.

The affinity-purified nature of the existing SPAC3F10.12c antibody provides a solid foundation for these advanced applications.

How might SPAC3F10.12c antibody contribute to comparative studies across different yeast species?

The SPAC3F10.12c antibody can facilitate comparative studies across yeast species through several approaches:

• Cross-Species Reactivity Assessment:

  • Systematically test the antibody against protein extracts from different yeast species (S. cerevisiae, C. albicans, K. lactis).

  • Identify conserved epitopes that enable cross-species detection.

  • Create a detailed cross-reactivity profile to understand evolutionary conservation of the protein structure.

• Functional Conservation Mapping:

  • Use the antibody to immunoprecipitate orthologous proteins from different yeast species.

  • Compare interacting partners to establish conservation of protein interaction networks.

  • Identify species-specific interactions that may explain phenotypic differences.

• Subcellular Localization Comparison:

  • Perform immunofluorescence studies across species to compare subcellular localization patterns.

  • Correlate localization differences with species-specific cellular organization.

  • Identify conserved targeting signals by comparing localization of truncated protein variants.

• Stress Response Profiling:

  • Apply identical stress conditions across yeast species.

  • Use the antibody to track protein abundance and modification changes.

  • Correlate differential responses with species-specific stress adaptation mechanisms.

• Evolutionary Rate Analysis:

  • Compare epitope recognition efficiency across species with known evolutionary distances.

  • Calculate relative evolutionary rates by correlating antibody binding affinity with sequence divergence.

  • Identify rapidly evolving regions that may indicate adaptive evolution.

The species reactivity of the SPAC3F10.12c antibody is specified as "yeast" , suggesting potential utility beyond S. pombe, though cross-reactivity would need experimental validation due to potential differences in protein conservation across yeast species.

What are the most common pitfalls when using SPAC3F10.12c antibody in fission yeast extract preparations?

When working with SPAC3F10.12c antibody in fission yeast extract preparations, researchers frequently encounter these challenges:

• Incomplete Cell Lysis:

  • Problem: Fission yeast has a robust cell wall that resists standard lysis buffers, resulting in low protein yield.

  • Solution: Implement mechanical disruption (glass beads, French press) combined with enzymatic pre-treatment (zymolyase at 5-10 mg/ml) to ensure complete cell wall breakdown.

• Protein Degradation:

  • Problem: Yeast vacuolar proteases can rapidly degrade proteins during extraction.

  • Solution: Use comprehensive protease inhibitor cocktails specifically optimized for yeast, containing PMSF (1 mM), pepstatin A (5 μg/ml), leupeptin (10 μg/ml), and aprotinin (2 μg/ml). Keep samples consistently cold (4°C or below).

• Poor Antibody Penetration:

  • Problem: Dense yeast cell wall components in incompletely processed samples can prevent antibody access.

  • Solution: Include brief sonication steps (3 x 10-second pulses) after enzymatic treatment to enhance extract accessibility.

• High Background in Immunoblotting:

  • Problem: Non-specific binding to highly abundant yeast proteins.

  • Solution: Implement extended blocking (overnight at 4°C) with 5% BSA and include 0.1% Tween-20 in all wash and antibody incubation steps.

• Variable Signal Intensity:

  • Problem: Inconsistent protein extraction efficiency between samples.

  • Solution: Normalize loading using multiple housekeeping proteins (e.g., actin and GAPDH) rather than a single reference protein.

• Cross-Reactivity with Related Proteins:

  • Problem: Polyclonal antibodies may recognize related protein domains.

  • Solution: Include extracts from SPAC3F10.12c deletion strains as negative controls in each experiment to identify non-specific bands.

The availability of both positive control antigens and negative control pre-immune serum should be leveraged in troubleshooting experiments to distinguish specific signals from artifacts.

How can researchers overcome challenges in detecting low-abundance SPAC3F10.12c protein?

For detecting low-abundance SPAC3F10.12c protein, implement these specialized approaches:

• Protein Concentration Methods:

  • TCA Precipitation: Add trichloroacetic acid to 10-20% final concentration to concentrate proteins before SDS-PAGE.

  • MWCO Filtration: Use 10 kDa molecular weight cut-off concentrators to enrich protein samples 10-50 fold.

  • Methanol-Chloroform Precipitation: Implement for samples containing detergents or salts that interfere with TCA precipitation.

• Signal Amplification Techniques:

  • Enhanced Chemiluminescence Plus (ECL+): Use higher-sensitivity substrates with multiple signal-generating cycles.

  • Tyramide Signal Amplification (TSA): Apply for immunofluorescence to amplify signal 10-100 fold.

  • Polymer-based Detection Systems: Employ HRP-polymer conjugates rather than simple enzyme-conjugated secondary antibodies.

• Sample Enrichment Strategies:

  • Subcellular Fractionation: Isolate the cellular compartment where SPAC3F10.12c is primarily located.

  • Immunoprecipitation-Western Blot: Concentrate the protein by immunoprecipitation before detection.

  • Tandem Affinity Purification: For tagged proteins, use sequential purification steps to reduce background.

• Detection System Optimization:

  • Extended Exposure Times: Use high-sensitivity digital imaging systems with extended exposure capability.

  • Cooled CCD Cameras: Employ for detection of extremely weak chemiluminescent signals.

  • Direct Digital Imaging: Use systems like Odyssey CLx for near-infrared fluorescence detection with wider dynamic range.

• Protocol Modifications:

  • Reduced Transfer Time: For smaller proteins, shorter transfer times prevent over-transfer through the membrane.

  • Extended Antibody Incubation: Increase primary antibody incubation to overnight at 4°C to maximize binding.

  • PVDF Membrane: Use PVDF rather than nitrocellulose for higher protein binding capacity.

The affinity-purified nature of the SPAC3F10.12c antibody should provide reasonable sensitivity, but these techniques can further enhance detection of low-abundance targets.